Is it safe for a female patient taking clonazepam 3 mg daily and bupropion extended‑release 300 mg each morning to use eszopiclone (Lunesta) for insomnia?

Lunesta (Eszopiclone) Use with Clonazepam 3mg and Bupropion XL 300mg

Adding Lunesta to this regimen carries significant risk and should be avoided or used only with extreme caution at the lowest possible dose (1mg), as the combination of high-dose clonazepam (3mg daily) with eszopiclone creates additive CNS depression that substantially increases the risk of cognitive impairment, respiratory depression, complex sleep behaviors, and serious injury.

Critical Safety Concerns

The FDA label for Lunesta explicitly warns that "LUNESTA, like other hypnotics, may produce additive CNS-depressant effects when coadministered with other psychotropic medications" and states that "dose adjustment may be necessary when LUNESTA is administered with other CNS-depressant agents, because of the potentially additive effects" 1. The clonazepam dose of 3mg daily is already at the high end of typical dosing, which amplifies these risks.

Specific Risks of This Combination:

• Complex sleep behaviors: The FDA warns that "the use of alcohol and other CNS depressants with LUNESTA appears to increase the risk of such behaviors" including sleep-driving, with the label stating these events warrant strong consideration for discontinuation 1

• Cognitive and memory impairment: Both benzodiazepines and eszopiclone carry risks for confusion and memory problems. In trials, LUNESTA 3mg caused memory impairment in 1.3% of patients even without concurrent benzodiazepines 1

• Respiratory depression: Combining two CNS depressants significantly increases this risk, particularly during sleep

• Falls and fractures: Observational data suggest hypnotics are associated with increased fracture risk, and this risk compounds with benzodiazepine use 2, 3

The Bupropion Component

Bupropion XL 300mg does not have significant pharmacokinetic interactions with eszopiclone and does not add to CNS depression. However, bupropion can be activating and may contribute to insomnia, raising the question of whether the underlying sleep problem could be medication-related rather than requiring additional hypnotics.

Evidence-Based Approach

First Priority: Address the Root Cause

Before adding a third sedating medication:

1. Evaluate if bupropion is contributing to insomnia - consider timing of dose or whether it's exacerbating sleep problems
2. Assess if the 3mg clonazepam dose is appropriate - this is a high dose that may indicate tolerance or dependence 4
3. Consider cognitive behavioral therapy for insomnia (CBT-I) - the American College of Physicians gives this a strong recommendation as first-line treatment 3

If Pharmacotherapy Must Be Added:

The safest approach is NOT to add Lunesta but rather to:

• Optimize the existing clonazepam regimen with CBT-I, which has been shown effective even in patients on benzodiazepines 4
• Consider tapering clonazepam (if clinically appropriate) before adding another hypnotic, as the combination creates unacceptable risk

If Lunesta Must Be Used Despite These Risks:

1. Start at 1mg only (not the standard 2-3mg doses studied in trials) 1
2. Warn the patient explicitly about:
   • Not driving or operating machinery for at least 8 hours after taking
   • Increased risk of falls, confusion, and complex sleep behaviors
   • Need to avoid alcohol completely
3. Monitor closely for cognitive changes, daytime sedation, and complex behaviors
4. Plan for short-term use only (FDA recommends 4-5 weeks maximum) 3
5. Consider this a bridge to non-pharmacologic therapy, not a long-term solution

Clinical Pitfalls to Avoid

• Do not use standard Lunesta dosing (2-3mg) in this context - the FDA specifically recommends dose reduction when combining with other CNS depressants 1
• Do not assume tolerance to clonazepam provides protection - the risks are additive, not mitigated by tolerance
• Do not continue indefinitely - both medications carry risks of dependence, and the combination amplifies this concern
• Do not ignore the possibility of benzodiazepine dependence - 3mg daily clonazepam for extended periods often indicates tolerance, and adding another hypnotic perpetuates the problem rather than solving it

Bottom Line

The combination of high-dose clonazepam with Lunesta is pharmacologically problematic and clinically inadvisable. The American College of Physicians guidelines emphasize that pharmacotherapy for insomnia should involve shared decision-making about risks versus benefits 3, and in this case, the risk-benefit ratio is unfavorable. The evidence supports pursuing CBT-I and potentially restructuring the existing medication regimen rather than adding a third sedating agent 2, 3.